|Videos|February 27, 2023
Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical
Author(s)Ascendia Pharma
Key Learning Objectives
- Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules
- Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing
- Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
5
